- Home
- MYFW vs ACRV Comparison
MYFW vs ACRV Comparison
Compare MYFW & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- ACRV
- Stock Information
- Founded
- MYFW 2002
- ACRV 2018
- Country
- MYFW United States
- ACRV United States
- Employees
- MYFW N/A
- ACRV N/A
- Industry
- MYFW Major Banks
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- MYFW Finance
- ACRV Health Care
- Exchange
- MYFW Nasdaq
- ACRV Nasdaq
- Market Cap
- MYFW 170.9M
- ACRV 189.0M
- IPO Year
- MYFW 2018
- ACRV 2022
- Fundamental
- Price
- MYFW $19.57
- ACRV $5.54
- Analyst Decision
- MYFW Buy
- ACRV Strong Buy
- Analyst Count
- MYFW 3
- ACRV 6
- Target Price
- MYFW $21.83
- ACRV $22.40
- AVG Volume (30 Days)
- MYFW 26.6K
- ACRV 69.3K
- Earning Date
- MYFW 04-17-2025
- ACRV 03-27-2025
- Dividend Yield
- MYFW N/A
- ACRV N/A
- EPS Growth
- MYFW N/A
- ACRV N/A
- EPS
- MYFW 0.26
- ACRV N/A
- Revenue
- MYFW $79,649,000.00
- ACRV N/A
- Revenue This Year
- MYFW N/A
- ACRV N/A
- Revenue Next Year
- MYFW $10.84
- ACRV N/A
- P/E Ratio
- MYFW $75.18
- ACRV N/A
- Revenue Growth
- MYFW N/A
- ACRV N/A
- 52 Week Low
- MYFW $12.84
- ACRV $3.83
- 52 Week High
- MYFW $22.32
- ACRV $11.90
- Technical
- Relative Strength Index (RSI)
- MYFW 42.09
- ACRV 47.59
- Support Level
- MYFW $20.60
- ACRV $5.00
- Resistance Level
- MYFW $21.70
- ACRV $6.08
- Average True Range (ATR)
- MYFW 0.62
- ACRV 0.64
- MACD
- MYFW -0.16
- ACRV 0.01
- Stochastic Oscillator
- MYFW 2.80
- ACRV 25.68
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.